Wockhardt Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: WOCKPHARMA BSE: 532300

₹2116.30

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #21 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Wockhardt Limited (this stock)	34,388	96.6	3.8%	41.8%	—	60	33	50

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹36,057 Cr

EV / EBITDA

50.4x

EV / Sales

19.11x

Market cap / Sales

18.22x

Earnings yield

1.03%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 594 Cr, up 35.6% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 107 Cr, up 55.1% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	561	107	107	₹6.6200
March 31, 2026	516	167	167	₹10.2900
Dec. 31, 2025	430	28	28	₹1.7300
Sept. 30, 2025	380	54	54	₹3.2600
June 30, 2025	413	69	69	₹4.2500
March 31, 2025	355	40	40	₹2.4700
Dec. 31, 2024	325	-22	-22	₹-1.4000
Sept. 30, 2024	370	-36	-36	₹-2.3400
June 30, 2024	352	6	6	₹0.3900
March 31, 2024	355	-126	-126	₹-8.7100
Dec. 31, 2023	288	-74	-74	₹-5.1400
Sept. 30, 2023	260	-107	-107	₹-7.3900
June 30, 2023	251	-115	-115	₹-8.0100

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	594	571	457	410	438	369	331	381	379	379	293	266	257
Operating revenue	561	516	430	380	413	355	325	370	352	355	288	260	251
Other income	33	55	27	30	25	14	6	11	27	24	5	6	6
Operating expenses	403	355	317	267	282	249	263	321	272	401	263	270	256
Operating profit	158	161	113	113	131	106	62	49	80	-46	25	-10	-5
Operating profit margin	28.2%	31.2%	26.3%	29.7%	31.7%	29.9%	19.1%	13.2%	22.7%	-13.0%	8.7%	-3.8%	-2.0%
Depreciation	41	43	52	45	46	40	42	43	43	45	43	44	44
Interest	43	41	50	44	41	40	48	53	58	59	61	59	58
Exceptional items, gain / (loss)	—	35	-10	—	—	—	—	—	—	—	—	—	-14
Profit before tax	107	167	28	54	69	40	-22	-36	6	-126	-74	-107	-115
Tax	—	—	—	—	—	—	—	—	—	—	—	—	—
Net profit	107	167	28	54	69	40	-22	-36	6	-126	-74	-107	-115
EPS	6.62	10.29	1.73	3.26	4.25	2.47	-1.40	-2.34	0.39	-8.71	-5.14	-7.39	-8.01
Net profit (TTM)	356	318	191	141	51	-12	-178	-230	-301	-422	-595	-576	-544
EPS (TTM)	21.90	19.53	11.71	8.58	2.98	-0.88	-12.06	-15.80	-20.85	-29.25	-41.34	-40.01	-37.79

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	1,739	317	317
March 31, 2025	1,402	-12	-12
March 31, 2024	1,154	-422	-422
March 31, 2023	1,072	-513	-466

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	16.2%	12.8%	1,876^†	1,460^†	1,195^†	1,197^†	1,404^†	1,028^†	1,310^†	2,181^†	2,534^†	2,549^†
Operating revenue	17.5%	12.0%	1,739	1,402	1,154	1,072	1,372^†	987^†	1,267^†	2,150^†	2,477^†	2,298^†
Other income	—	—	137^†	58^†	41^†	125^†	32^†	41^†	43^†	31^†	57^†	252^†
Operating expenses	—	—	1,221^†	1,105^†	1,190^†	1,060^†	1,144^†	1,125^†	1,284^†	2,064^†	2,154^†	—
Operating profit	250.8%	—	518^†	297^†	-36^†	12^†	228^†	-138^†	-17^†	86^†	323^†	—
Operating profit margin	—	—	29.8%^†	21.2%^†	-3.1%^†	1.1%^†	16.6%^†	-13.9%^†	-1.3%^†	4.0%^†	13.0%^†	—
Depreciation	—	—	186^†	168^†	176^†	186^†	171^†	184^†	175^†	122^†	106^†	—
Interest	—	—	176^†	199^†	237^†	229^†	273^†	200^†	220^†	171^†	170^†	169^†
Exceptional items, gain / (loss)	—	—	25^†	0^†	-14^†	-235^†	0^†	-142^†	0^†	0^†	0^†	0^†
Profit before tax	—	—	317	-12	-422	-513	-184^†	-624^†	-369^†	-175^†	104^†	119^†
Tax	—	—	—	—	—	—	-45^†	-232^†	-118^†	-94^†	35^†	-18^†
Net profit	—	—	317	-12	-422	-466	-140^†	—	—	-82^†	69^†	137^†
EPS	—	—	19.53^†	-0.88^†	-29.25^†	-32.40^†	-12.97^†	-35.40^†	-22.66^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	29.8%^†	21.2%^†	-3.1%^†	1.1%^†	16.6%^†	-13.9%^†	-1.3%^†	4.0%^†	13.0%^†	—
EBIT margin	28.3%^†	13.3%^†	-16.0%^†	-26.5%^†	6.5%^†	-42.9%^†	-11.7%^†	-0.2%^†	11.0%^†	12.5%^†
PBT margin	18.2%	-0.9%	-36.6%	-47.9%	-13.4%^†	-63.2%^†	-29.1%^†	-8.2%^†	4.2%^†	5.2%^†
Net margin	18.2%	-0.9%	-36.6%	-43.5%	-10.2%^†	—	—	-3.8%^†	2.8%^†	6.0%^†
Interest coverage	2.80x^†	0.94x^†	-0.78x^†	-1.24x^†	0.32x^†	-2.12x^†	-0.68x^†	-0.03x^†	1.61x^†	1.70x^†
Dividend payout	0.0%^†	—	—	—	—	—	—	—	—	—
Earnings retention	100.0%^†	—	—	—	—	—	—	—	—	—
Current ratio	1.61x	1.34x	—	—	—	—	—	—	—	—
Quick ratio	1.23x	1.05x	—	—	—	—	—	—	—	—
Debt to equity	0.57x	0.55x	—	—	—	—	—	—	—	—
Return on equity	10.3%	-0.4%	—	—	—	—	—	—	—	—
Return on assets	5.3%	-0.2%	—	—	—	—	—	—	—	—
Return on capital employed	10.9%^†	4.8%^†	—	—	—	—	—	—	—	—
Asset turnover	0.29x	0.26x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	241	-193	-7	86	155
March 31, 2025	-14	-900	486	41	-55
March 31, 2024	188	-75	346	2	186
March 31, 2023	71	-3	-236	0	71
March 31, 2022	-93	-244	430	52	-145

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	5,935	3,084	3,003	501	1,244	2,290	1,426	76	1,128	533
March 31, 2025	5,408	2,763	2,682	590	937	1,990	1,483	35	1,240	426
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.